disease, such as bowing or advancing radiolucent wedge (Fig. 2) . Bone scanning showed a focal area of diffuse increased activity around the left tibial lesion, including the patella and femur. Serum alkaline phosphatase, calcium, and phosphate levels were normal. Lactate dehydrogenase levels were marginally raised. The 24-hour urine examination showed a marginally raised hydroxyproline level of 444 µmol/dl (normal range, 120-320 µmol/dl). A second biopsy showed the presence of irregular dilated vessels with an associated decrease in bone trabeculae. No osteoclastic activity or prominent cement lines were visible. The histological findings were thus not typical of Paget's disease and were more indicative of a vascular lesion ( Fig. 3 ). In the light of the histological findings and the isolated bone involvement, the lesion was identified to be an unusual form of skeletal angiomatosis that involved one single osseous site, with associated osteolysis. Further progression of the osteolysis was evident during the observation period, and a course of palmidronate was used in an attempt to halt the disease process. The patient was given 60 mg intravenous infusion of palmidronate over one hour. He was also given supplement of calcium carbonate 1250 mg and calcitriol 0.5 µg once daily for 6 months to maximise calcium absorption. The palmidronate infusion was repeated monthly for 6 months. Radiotherapy was not given. Progress was monitored by clinical symptoms and plain X-rays. Because of the possible risk of reavulsion of the tibial tubercule, the patient was allowed to walk only with toe touch down and assistance of crutches, during palmidronate treatment, and with a hinged knee brace. Vol . 11 No. 1, June 2003 Bisphosphonate for avulsion fracture of tibial tuberosity 99
As a time lag was expected for conventional Xrays to document new bone formation, bone densitometry (dual energy X-ray absorptiometry [DEXA]) technique was used to document the healing process and the bone mineral density changes during treatment with bisphosphonate (QDR 4500; Hologic Inc., Waltham, United States). The affected knee showed a definite increase in bone density after palmidronate treatment was commenced. The rate of increase of the bone density was uniform and peaked at the same time period for the different sampling areas. There was a subsequent decrease in the density, followed by another increase (Fig. 4 ). There were no such changes on the normal side, and there was no increase in bone density of the unaffected bone.
By one year after treatment, there was complete resolution of symptoms, return of full range of motion to the knee, and radiological consolidation of the tibia and static DEXA parameters for 6 months (Fig. 5 ). We thus recommended that the original screws be removed and a biopsy of the healed area be repeated. Histological investigation showed morphologically normal cortical and cancellous bone with no conspicuous osteoblastic or osteoclastic activity. The cement lines were not prominent and no vascular component was visible.
The patient remained well and symptom-free at 3 years since treatment.
DISCUSSION
Spontaneous avulsion fracture of the tibial tuberosity in adults is uncommon and, in this case, occurred in bone with underlying angiomatosis. Making the diagnosis in this case was challenging. The initial histology was very limited and showed certain histological features of Paget's disease. However, the radiological features, biochemical findings, clinical presentation, and its subsequent clinical course were most unusual features of Paget's disease. Furthermore, Paget's disease is extremely rare among the Chinese population. 1 Massive osteolysis has been reported under numerous different names since it was first mentioned in the English literature in 1838. 2 Its clinical and pathological features were first clearly described in 1954 by Gorham et al. 3, 4 Hence, it is often called Gorham's disease. The largest series in the literature consisted of only 7 cases. 5 The rarity of this condition means that no single centre can develop any extensive experience of this condition. It is therefore important that new methods of treatment be shared and the experience collectively gathered albeit at a slow pace. The diagnosis of such a rare disease is often delayed and is made only with a high index of suspicion and exclusion of other diseases. Some investigators of this disease 6 suggested including criteria such as positive biopsy results for angiomatosis; absence of cellular atypia; minimal osteoblastic response; evidence of local progressive osseous resorption; nonulcerative lesion; absence of visceral involvement; osteolytic radiographic pattern; negative hereditary, metabolic, and infectious aetiology, to make the diagnosis of Gorham's disease. Using these criteria, this case is consistent with the diagnosis of Gorham's disease, or at least a mild variant of it. Gorham's disease is a rare condition and may present as a pathological fracture. The pathological process is not well known, but it has been postulated to relate to the underlying vascular abnormality. 7 There are sporadic reports of treatment using radiotherapy, 8 but it is also known that the condition can be selflimiting. 9 The difficulty is knowing which cases will and which will not be self-limiting. Magnetic resonance image features, triple-phase radionuclide bone scan results, and thallium scan results have been reported by Livesley et al. 10 However, they provide very little useful practical information, except perhaps to confirm the mono-ostotic nature of the disease. They cannot document the intensity of the disease nor the degree of response of the bone.
Some studies suggest that osteolysis in Gorham's disease is possibly a local disturbance of osteoclastic activity. 11, 12 Bisphosphonate may be an alternative form of treatment, 12 and experience with this drug in metastatic breast cancer supports its anti-osteoclastic property. 13 Empirical use of palmidronate infusion in the patient in this case led to a satisfactory outcome, al-though the exact mechanism of bisphosphonate in the management of Gorham's disease remained unclear.
Conventional fracture treatment alone was unsuccessful in this case. Bisphosphonate was useful in the treatment of osteolysis and we were able to monitor the clinical course by serial DEXA examination. However, bisphosphonate was not needed for the whole course of the disease. We thus postulate that once bisphosphonate somehow temporarily halts the osteolytic process, then the normal bone response sets in. It was reassuring to observe that the normal bone was not affected by the drug. There is always a worry that generalised osteosclerosis may lead to stress fractures elsewhere. The bone density of the affected limb clearly showed a uniform response rate to bisphosphonate treatment. This combination of radiological and DEXA monitoring helped the patient to ambulate with full weightbearing after 6 months' treatment. After DEXA showed a plateau of improvement of bone density, we then removed the implants to maximise the potential of the final remodelling phase.
In conclusion, we have reported an unusual case of monostotic angiomatosis of the tibial tuberosity presenting with avulsion fracture and osteolysis, which showed a good response to empirical bisphosphonate treatment. The clinical course and radiological and histological findings indicate that this was probably a mild variant case of massive osteolysis (Gorham's disease). We have also demonstrated the value of sequential follow-up using DEXA for patients with osteolysis.
